Xention Enters Drug Discovery Agreement with Ono Pharmaceutical Co., Ltd.
16-Mar-2009 -
Xention Ltd announced that it has signed a Drug Discovery Agreement with Ono Pharmaceutical Co., Ltd. Under the terms of the Agreement, Xention will apply its proprietary ion channel drug discovery platform to the identification, design and synthesis of small molecules against ion channels ...
ion channel drugs
ion channels
ligands
+1